Humana enters $5.0 billion unsecured revolving credit agreement, replacing prior facilities
Humana entered a $5.0 billion unsecured revolving credit agreement on May 30, 2025, which increases its existing 5-year commitments from $2.642 billion and replaces a 364-day $2.1 billion facility. As of May 30, 2025, the company had no borrowings outstanding and about $4.98 billion of remaining borrowing capacity, so the change adds liquidity without new debt drawn. The filing is administrative in nature, and the agreement includes a maximum debt to capitalization covenant that shareholders may want to note.
Key points
- New facility totals $5.0 billion, unsecured, and permits up to $1.0 billion of incremental commitments
- Increases existing 5-year commitments from $2.642 billion and replaces a 364-day $2.1 billion agreement dated May 31, 2024
- As of May 30, 2025, no borrowings outstanding and about $14.7 million of undrawn letters of credit, leaving about $4.98 billion available
- Full agreement to be filed as an exhibit to the Form 10-Q for the six months ending June 30, 2025
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 30, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.